Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Chan

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|April 5, 2007
Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptideSimon Kollnberger, Antoni Chan, Mei-Yi Sun, et al.
Annals of the Rheumatic Diseases|July 2, 2015
Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitisLiye Chen, Anna Ridley, Ariane Hammitzsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblastsAntoni Chan, Deng-Li Hong, Ann Atzberger, et al.
Rheumatology Advances in Practice|August 15, 2020
Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational studyLiz Van Rossen, Antoni Chan, Annie Gilbert, et al.
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trialSofia Ramiro, Cédric Lukas, Michael J Nissen, et al.
EULAR Rheumatology Open|June 29, 2026
Five years of the Digital Rheumatology Network: insights and future directionsAntoni Chan, Johannes Knitza, Vincenzo Venerito, et al.
The Lancet. Rheumatology|June 28, 2024
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trialClaudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, et al.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|April 5, 2007
Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptideSimon Kollnberger, Antoni Chan, Mei-Yi Sun, et al.
Annals of the Rheumatic Diseases|July 2, 2015
Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitisLiye Chen, Anna Ridley, Ariane Hammitzsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblastsAntoni Chan, Deng-Li Hong, Ann Atzberger, et al.
Rheumatology Advances in Practice|August 15, 2020
Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational studyLiz Van Rossen, Antoni Chan, Annie Gilbert, et al.
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trialSofia Ramiro, Cédric Lukas, Michael J Nissen, et al.
EULAR Rheumatology Open|June 29, 2026
Five years of the Digital Rheumatology Network: insights and future directionsAntoni Chan, Johannes Knitza, Vincenzo Venerito, et al.
The Lancet. Rheumatology|June 28, 2024
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trialClaudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, et al.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 4